VANCOUVER, BC / ACCESSWIRE / June 27, 2022 / Verisante Technology Inc. (NEX:VER.H) (the “Company”) announces that further to the Company’s announcement of June 5, 2022, it has received final TSX-V Exchange acceptance and will now issue 15,154,182 pre-consolidation common shares at a deemed price of $0.05 per pre-consolidation share to settle $757,709.10 of outstanding debt. All shares issued pursuant to the Shares for Debt Transactions will be subject to a four-month-plus-one-day hold period from the date of issuance.
The Company also received exchange acceptance to issue 200,000 pre-consolidation common shares at a price of $0.05 for $10,000 pursuant to a subscription received on April 27, 2018. These transactions were suspended when the Company was subject to a Failure to File Cease Trade Order on May 4, 2018 which was revoked on April 6, 2022. All shares issued pursuant to the shares for debt and private placement will be subject to a four-month-plus-one-day hold period from the date of issuance. No finders’ fees will be paid in connection with either of the transactions. As previously announced on June 23, 2022, the Company consolidated its common shares on a 10 for 1 basis and changed its ticker symbol to “VER.H”.
The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this news release.
Company Contact:
Thomas Braun, President & CEO
Verisante Technology, Inc.
Telephone: (604) 716-5133
Email: info@verisante.com
Forward Looking Statements:
This release contains forward-looking statements all of which statements are subject to market risks, and the possibility that the Company will not be able to achieve all of its stated goals. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
SOURCE: Verisante Technology Inc.
View source version on accesswire.com:
https://www.accesswire.com/706724/Verisante-Technology-Inc-Announces-Share-Issuance
Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…
NEW YORK, July 9, 2024 /PRNewswire/ -- Scanning electrochemical microscopy (SECM) is used for imaging…
SAN DIEGO, July 9, 2024 /PRNewswire/ -- Puro Sound Labs, a leader in safe listening technology,…
NEW YORK, July 9, 2024 /PRNewswire/ -- Real-time Location Systems (RTLS) are technologies used to…
Accessible, highly scalable single-cell technology expands Illumina's multiomics capabilities SAN DIEGO, July 9, 2024 /PRNewswire/ --…
U.S. health systems are increasingly embracing ambient documentation solutions to reduce providers' administrative workloads and…